USMS Narcan/Naloxone Kit
Closed Solicitation Posted
- Solicitation number
- 15M10424QA4700009
- Agency
-
US Marshals Service
Department of Justice
- Responses due
- Set-aside
- Total Small Business
Opportunity facts
- Place of performance
- Arlington, Virginia, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
The United States Marshals Service (USMS) is seeking a Blanket Purchase Agreement (BPA) for opioid reversal medication kits and equipment to support its Operational Medical Support Unit. The solicitation requires a vendor to provide four distinct kit configurations, including a Complete Kit with Narcan/Naloxone, face shields, and gloves, as well as three additional restock and variant kits. Proposals will be evaluated using a lowest-priced technically acceptable (LPTA) methodology, with offerors required to submit a PowerPoint presentation showcasing kit samples, technical specifications, and a management plan. Potential vendors must carefully follow the detailed submission instructions, which include a 20-slide maximum presentation and a 5-page management plan. Key deadlines include questions due by January 20, 2025 at 1:00 PM EST and final quotes due by February 14, 2025 at 1:00 PM EST.
The contract is designated as a 100% small business set-aside under NAICS code 423450, with a size standard of 200 employees, and will utilize Federal Acquisition Regulation (FAR) Part 13 procedures. The BPA will cover a base period and four one-year option periods, spanning from March 15, 2025 to March 14, 2030, with estimated annual quantities including 4,000 Complete Kits, 500 Kit Less Naloxone units, 500 Restock Kit V1 units, and 3,800 Restock Kit V2 units. Delivery will be required to USMS locations throughout the continental United States, territories, Alaska, and Hawaii, with 4-6 week delivery timelines depending on order size. The contract will be administered by the USMS Office of Emergency Management in Springfield, VA, with payment terms set at NET 30 and invoicing processed through the Invoice Processing Platform. While no specific award value is disclosed, the multi-year structure suggests a substantial procurement opportunity for qualified small businesses.
Notice text
2 versions
Update #2 · Latest ·
AMENDMENT 0001
The purpose of Amendment 0001 is as follows:
1. Post Q/A that have been submitted to 1/17/25, document attached/named Questions and responses Amendment 0001
2. Important clarifications to the SOW. PLEASE REVIEW THE UPDATED SOW, document attached/named Statemenrt of Work Narcan Amendment 0001
The United States Marshals Service (USMS), Tactical Operations Division (TOD), Office of Emergency Management (OEM), Operational Medical Support Unit (OMSU) has a requirement to provide USMS Districts and Divisions a procurement vehicle to purchase opioid reversal medications and equipment as part of the USMS Opioid Reversal Program.
USMS intends to award a Firm-Fixed-Price (FFP) BPA in accordance with FAR Part 13 as a Small Business Set-Aside that will allow both USMS Districts and Divisions to place orders to procure for operational employees on an as needed basis. The BPA shall include a FFP for each of the unique options available to USMS Districts and Divisions. Orders under this BPA will be issued as call orders as well as Government purchase card orders on an as needed basis. The anticipated period of performance includes one (1) base period and four (4) one year option periods.
The Government is under no obligation to contract for any supplies or services as a result of this solicitation. The Government will not compensate any respondent for any costs associated with developing a quote in response to this solicitation.
Place of Performance/shipping:
Orders will be placed by and shipped to all requesting USMS offices which includes addresses CONUS and OCONUS.
The anticipated period of performance is March 15, 2025 to March 14, 2030 which includes one (1) 12-month base period and four one (1) year option periods. These dates are not guaranteed and can change before award, providing an award is made.
Instructions
See attached documents, in particular Attachment 2 – Instructions to Offeror for all information necessary to respond to this requirement. NO phone calls will be accepted with questions related to this requirement. Questions and quotes will be accepted via email per the attached instructions only.
Questions are due 1:00 PM EST on January 20, 2025
Quotes are due: 1:00 PM EST on February 14, 2025
Update #1 ·
The United States Marshals Service (USMS), Tactical Operations Division (TOD), Office of Emergency Management (OEM), Operational Medical Support Unit (OMSU) has a requirement to provide USMS Districts and Divisions a procurement vehicle to purchase opioid reversal medications and equipment as part of the USMS Opioid Reversal Program.
USMS intends to award a Firm-Fixed-Price (FFP) BPA in accordance with FAR Part 13 as a Small Business Set-Aside that will allow both USMS Districts and Divisions to place orders to procure for operational employees on an as needed basis. The BPA shall include a FFP for each of the unique options available to USMS Districts and Divisions. Orders under this BPA will be issued as call orders as well as Government purchase card orders on an as needed basis. The anticipated period of performance includes one (1) base period and four (4) one year option periods.
The Government is under no obligation to contract for any supplies or services as a result of this solicitation. The Government will not compensate any respondent for any costs associated with developing a quote in response to this solicitation.
Place of Performance/shipping:
Orders will be placed by and shipped to all requesting USMS offices which includes addresses CONUS and OCONUS.
The anticipated period of performance is March 15, 2025 to March 14, 2030 which includes one (1) 12-month base period and four one (1) year option periods. These dates are not guaranteed and can change before award, providing an award is made.
Instructions
See attached documents, in particular Attachment 2 – Instructions to Offeror for all information necessary to respond to this requirement. NO phone calls will be accepted with questions related to this requirement. Questions and quotes will be accepted via email per the attached instructions only.
Questions are due 1:00 PM EST on January 20, 2025
Quotes are due: 1:00 PM EST on February 14, 2025
Files
| File | Type | Posted |
|---|---|---|
| Statement of Work Narcan Amendment 0001.pdf | ||
| Questions and responses Amendment 0001.pdf | ||
| Statement of Work Narcan Final.pdf | ||
| Attachment Pricing Spreadsheet.xlsx | XLSX spreadsheet | |
| Attachment 2 - Instructions to Offerors Final.pdf | ||
| 15M10424QA4700009 FINAL.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity